Development and Validation of a Scoring System to Predict Outcomes of Patients with Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy

Gastroenterology

Volumn 149, Issue 7, 2015, Pages 1804-1812.e4

  Lammers, Willem J ^a   Hirschfield, Gideon M ^b   Corpechot, Christophe ^c   Nevens, Frederik ^d   Lindor, Keith D ^e,f   Janssen, Harry L A ^g   Floreani, Annarosa ^h   Ponsioen, Cyriel Y ⁱ   Mayo, Marlyn J ^j   Invernizzi, Pietro ^k   Battezzati, Pier M ^l   Parés, Albert ^m   Burroughs, Andrew K ⁿ   Mason, Andrew L ^o   Kowdley, Kris V ^p   Kumagi, Teru ^q   Harms, Maren H ^a   Trivedi, Palak J ^b   Poupon, Raoul ^c   Cheung, Angela ^g   Lleo, Ana ^k   Caballeria, Llorenç ^m   Hansen, Bettina E ^a   Van Buuren, Henk R ^a   more..

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c HÔPITAL SAINT ANTOINE   (France)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e MAYO CLINIC   (United States)

^f ARIZONA STATE UNIVERSITY   (United States)

^g TORONTO WESTERN HOSPITAL   (Canada)

^h UNIVERSITY OF PADOVA   (Italy)

ⁱ ACADEMIC MEDICAL CENTER   (Netherlands)

^j UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^k HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^l UNIVERSITY OF MILAN   (Italy)

^m UNIVERSITY OF BARCELONA   (Spain)

ⁿ ROYAL FREE HOSPITAL   (United Kingdom)

^o UNIVERSITY OF ALBERTA   (Canada)

^p SWEDISH MEDICAL CENTER   (United States)

^q EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

Autoimmune Liver Disease; Cholestasis; Predictive Factor; Prognosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; URSODEOXYCHOLIC ACID; BIOLOGICAL MARKER; CHOLAGOGUE;

ADULT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; DEATH; DISEASE SEVERITY; FEMALE; GLOBE SCORE; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SURVIVAL; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TRANSPLANTATION FREE SURVIVAL; VALIDATION STUDY; AGED; BLOOD; CLINICAL TRIAL; DECISION SUPPORT SYSTEM; DISEASE COURSE; DISEASE FREE SURVIVAL; EUROPE; KAPLAN MEIER METHOD; LIVER CIRRHOSIS, BILIARY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NORTH AMERICA; PROPORTIONAL HAZARDS MODEL; REPRODUCIBILITY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; TIME; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; BIOMARKERS; CHOLAGOGUES AND CHOLERETICS; DECISION SUPPORT TECHNIQUES; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; EUROPE; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER CIRRHOSIS, BILIARY; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NORTH AMERICA; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME; URSODEOXYCHOLIC ACID;

EID: 84952986849     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2015.07.061     Document Type: Article

References (39)

1. C. Selmi, C.L. Bowlus, M.E. Gershwin, and et al. Primary biliary cirrhosis Lancet 377 2011 1600 1609
2. K.D. Lindor, M.E. Gershwin, R. Poupon, and et al. Primary biliary cirrhosis Hepatology 50 2009 291 308
3. European Association for the Study of the Liver EASL Clinical Practice Guidelines: management of cholestatic liver diseases J Hepatol 51 2009 237 267
4. P. Angulo, K.P. Batts, T.M. Therneau, and et al. Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis Hepatology 29 1999 644 647
5. C. Corpechot, F. Carrat, A.M. Bonnand, and et al. The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis Hepatology 32 2000 1196 1199
6. R.E. Poupon, K.D. Lindor, A. Pares, and et al. Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis J Hepatol 39 2003 12 16
7. C. Corpechot, F. Carrat, A. Bahr, and et al. The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis Gastroenterology 128 2005 297 303
8. P.C. ter Borg, S.W. Schalm, B.E. Hansen, and et al. Prognosis of ursodeoxycholic Acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients Am J Gastroenterol 101 2006 2044 2050
9. A. Pares, L. Caballeria, and J. Rodes Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid Gastroenterology 130 2006 715 720
10. C. Corpechot, L. Abenavoli, N. Rabahi, and et al. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis Hepatology 48 2008 871 877
11. E.M. Kuiper, B.E. Hansen, R.A. de Vries, and et al. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid Gastroenterology 136 2009 1281 1287
12. T. Kumagi, M. Guindi, S.E. Fischer, and et al. Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis Am J Gastroenterol 105 2010 2186 2194
13. C. Corpechot, O. Chazouilleres, and R. Poupon Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome J Hepatol 55 2011 1361 1367
14. M. Carbone, G.F. Mells, G. Pells, and et al. Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid Gastroenterology 144 2013 560 569 e7 quiz e13-e14
15. P.J. Trivedi, T. Bruns, A. Cheung, and et al. Optimising risk stratification in primary biliary cirrhosis: AST/platelet ratio index predicts outcome independent of ursodeoxycholic acid response J Hepatol 60 2014 1249 1258
16. Trivedi PJ, Lammers WJ, van Buuren HR, et al. Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study. Gut Jan 7. pii: gutjnl-2014-308351. http://dx.doi.org/10.1136/gutjnl-2014-308351. [Epub ahead of print].
17. W.J. Lammers, H.R. van Buuren, A. Pares, and et al. Defining optimal laboratory response cirteria in UDCA treated primary biliary cirrhosis. Results of an international multicenter long-term follow-up study Hepatology 58 2013 249A
18. W.J. Lammers, H.R. van Buuren, G.M. Hirschfield, and et al. Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study Gastroenterology 147 2014 1338 1349
19. R. Little, and D. Rubin Statistical Analysis With Missing Data 1987 John Wiley & Sons, Inc. New York
20. J.J. Goeman L1 penalized estimation in the Cox proportional hazards model Biomed J 52 2010 70 84
21. E.W. Steyerberg Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating 2009 Springer New York
22. P. Royston, and D.G. Altman External validation of a Cox prognostic model: principles and methods BMC Med Res Methodol 13 2013 33
23. M.J. Pencina, R.B. D'Agostino Sr., R.B. D'Agostino Jr., and et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172 discussion 207-212
24. M.J. Leening, M.M. Vedder, J.C. Witteman, and et al. Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician's guide Ann Intern Med 160 2014 122 131
25. E.R. Dickson, P.M. Grambsch, T.R. Fleming, and et al. Prognosis in primary biliary cirrhosis: model for decision making Hepatology 10 1989 1 7
26. E. Christensen, J. Neuberger, J. Crowe, and et al. Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial Gastroenterology 89 1985 1084 1091
27. J.M. Shapiro, H. Smith, and F. Schaffner Serum bilirubin: a prognostic factor in primary biliary cirrhosis Gut 20 1979 137 140
28. P. Krzeski, W. Zych, E. Kraszewska, and et al. Is serum bilirubin concentration the only valid prognostic marker in primary biliary cirrhosis? Hepatology 30 1999 865 869
29. A.M. Bonnand, E.J. Heathcote, K.D. Lindor, and et al. Clinical significance of serum bilirubin levels under ursodeoxycholic acid therapy in patients with primary biliary cirrhosis Hepatology 29 1999 39 43
30. C.G. Child, and J.G. Turcotte Surgery and portal hypertension Major Probl Clin Surg 1 1964 1 85
31. R.N. Pugh, I.M. Murray-Lyon, J.L. Dawson, and et al. Transection of the oesophagus for bleeding oesophageal varices Br J Surg 60 1973 646 649
32. P.S. Kamath, R.H. Wiesner, M. Malinchoc, and et al. A model to predict survival in patients with end-stage liver disease Hepatology 33 2001 464 470
33. N. Momah, M.G. Silveira, R. Jorgensen, and et al. Optimizing biochemical markers as endpoints for clinical trials in primary biliary cirrhosis Liver Int 32 2012 790 795
34. P. Angulo, K.D. Lindor, T.M. Therneau, and et al. Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid Liver 19 1999 115 121
35. I. Patanwala, P. McMeekin, R. Walters, and et al. A validated clinical tool for the prediction of varices in PBC: the Newcastle Varices in PBC Score J Hepatol 59 2013 327 335
36. S. Joshita, T. Umemura, M. Ota, and et al. AST/platelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary biliary cirrhosis J Hepatol 61 2014 1443 1445
37. P. Royston, D.G. Altman, and W. Sauerbrei Dichotomizing continuous predictors in multiple regression: a bad idea Stat Med 25 2006 127 141
38. J. Roll, J.L. Boyer, D. Barry, and et al. The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis N Engl J Med 308 1983 1 7
39. C. Corpechot, F. Carrat, A. Poujol-Robert, and et al. Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis Hepatology 56 2012 198 208